Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10
10/12/2011 5:55:21 AM
More...
|
Shield Therapeutics Raises EUR8.2 Million From Inventages Venture Capital Via Series A Institutional Round
6/1/2011 6:47:48 AM
More...
|
Shield Therapeutics Appoints Richard Jones as Chief Financial Officer
5/16/2011 10:54:48 AM
More...
|
Shield Therapeutics to Present at the Biotech Showcase 2011
1/7/2011 10:43:54 AM
More...
|